ACCESSIBILITY

24/7

Headlines

15:36

Israel to invest over $30M in groundbreaking lab for bio-devices and biochips development

15:32

"People worry AI will replace them, but those who master it will thrive"

15:24

War games of a different kind: Games developed in this war have a higher purpose

15:11

"AI will not replace game developers - it will make their lives easier"

Buzz

Most popular

Daily

Weekly

Have missiles from the Iranian-backed Houthis discovered a loophole in Israeli air defenses?

Kaltura CEO: "Just like a missile hit our office, a missile hit us with the IPO"

Windward acquired for $270M by FTV Capital, doubling its IPO valuation

$41B in exits: Why Israeli cyber startups are a global powerhouse

8 Israeli cyber companies travel to the UK for collaboration opportunities

More news

Teva

12 stories about Teva

Teva Sells IUD Business for $1.1 Billion

12.09.17|Lilach Baumer

Going forward, the company will focus on central nervous system and respiratory treatments, shedding its Women's Health and Oncology and Pain businesses

New CEO to Break Teva’s Copaxone Habit

11.09.17|Sophie Shulman, Dror Reich

Troubled drugmaker says new CEO must work to quickly regain its financial credibility

Teva Appoints Lundbeck's Schultz as CEO

11.09.17|Dror Reich and Micky Grunfeld

The company’s announcement brings an end to a seven month search for a CEO to lead the troubled generic drugmaker. Updated

Bidders Line Up for Teva’s Women Health Unit, Report Says

23.08.17|Dror Reich

Church & Dwight Co. and Cooper Companies Inc. join other bidders for troubled drugmaker assets, Bloomberg reported Tuesday

U.S. Congress to Investigate Rising Multiple Sclerosis Drug Prices

21.08.17|Dror Reich

Two Congressmen are looking into the rising MS drug prices of seven pharmaceutical companies

Cerberus, Advent Eye Teva's European Assets, Report Says

15.08.17|Calcalist

The private equity firms are taking an interest in Teva's European oncology and pain treatment assets, estimated at $700 million to 1$ billion, according to a Bloomberg report

Allergan Sketches Road Show to Sell Teva Stake

14.08.17|Golan Hazani

The company is in discussions with investment bankers and brokers to sell its Teva shares, said one person familiar with the matter

With Bloated Debt, Teva Looks to Sell Assets

10.08.17|Eli Shimony and Gil Kalian

The generic drugmaker said it is looking to sell Medis, an Iceland-based company it bought in 2016

Teva’s Perfect Storm Sends Tel-Aviv Stock Exchange Down

06.08.17|Calcalist

Teva’s stock price dropped sharply on Thursday and Friday after the company released quarterly revenue and profits that fell short of analysts’ forecasts

מנכ"ל AstraZeneca פסקל סוריו Pascal Soriot

Soriot's Teva Appointment Unlikely, Says Activist Investor

06.08.17|Golan Hazani

Teva’s board was surprised to learn AstraZeneca's CEO Pascal Soriot will not be joining the company. Teva activist investor Benny Landa called an early report on Teva's negotiations with Mr. Soriot "devastating"

Allergan Can Now Sell 9.8% Teva Stake

03.08.17|Dror Reich

Yesterday, a lock-up period on $3.2 billion worth Teva Pharmaceutical Industries’ shares owned by Allergan ended

Teva in Talks to Appoint AstraZenca's Pascal Soriot as CEO

18.07.17|Golan Hazani

Mr. Soriot has met with the company’s search committee and its chairman and expressed his agreement to serve as its next CEO, people familiar with the matter said